Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Proteasome Inhibitor Therapy for Waldenström's Macroglobulinemia — Meletios A Dimopoulos (2013) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Proteasome Inhibitor Therapy for Waldenström's Macroglobulinemia
Shared by
Meletios A Dimopoulos
Proteasome Inhibitor Therapy for Waldenström's Macroglobulinemia
Article
2013
en
Authors
Meletios A Dimopoulos
ET
Evangelos Terpos
EK
Efstathios Kastritis
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2023
Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia
Eirini Solia
,
Meletios A Dimopoulos
,
Efstathios Kastritis
Article
2018
Proteasome Inhibitors in Waldenström Macroglobulinemia
Efstathios Kastritis
,
Meletios A Dimopoulos
Chapter in a book
2016
Immunomodulatory Agents and Proteasome Inhibitors in Waldenstrom’s Macroglobulinemia
Steven P. Treon
,
Jorge J. Castillo
,
Efstathios Kastritis
,
Meletios A Dimopoulos
Article
1993
Fludarabine therapy in Waldenström's macroglobulinemia
Meletios A Dimopoulos
,
Susan O’Brien
,
Hagop M. Kantarjian
,
Sherry Pierce
,
Kay Delasalle
,
B Barlogie
,
Raymond Alexanian
,
Michael J. Keating
Chapter in a book
2007
Novel Options of Therapy in Waldenström Macroglobulinemia
Irene M. Ghobrial
,
Anne‐Sophie Moreau
,
Xavier Leleu
,
Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.